French Minister of Higher Education, Research and Innovation Frederique Vidal and Junior Defence Minister Genevieve Darrieussecq, wearing protective face masks, attend the questions to the government session at the National Assembly in Paris, France, June 23, 2020. REUTERS/Benoit Tessier

French Minister of Higher Education, Research and Innovation Frederique Vidal, wearing a protective face mask, speaks during the questions to the government session at the National Assembly in Paris, France, June 23, 2020. REUTERS/Benoit Tessier

Canada's Minister of Innovation, Science and Industry Navdeep Bains speaks during a meeting of the special committee on the COVID-19 pandemic, as efforts continue to help slow the spread of the coronavirus disease (COVID-19), in the House of Commons on Parliament Hill in Ottawa, Ontario, Canada June 16, 2020. REUTERS/Blair Gable

U.S. Attorney General Bill Barr speaks with Ja’Ron Smith, Deputy Assistant to the President and Deputy Director of the White House Office of American Innovation as President Donald Trump holds a roundtable discussion with members of the faith community, law enforcement and small business at Gateway Church Dallas Campus in Dallas, Texas, U.S., June 11, 2020. REUTERS/Jonathan Ernst

French Minister of Higher Education, Research and Innovation Frederique Vidal leaves the Elysee Presidential Palace after a weekly cabinet meeting, in Paris, France May 27, 2020 as France eases lockdown measures taken to curb the spread of the coronavirus disease COVID-19. Ludovic Marin/Pool via REUTERS

Canada's Minister of Innovation, Science and Industry Navdeep Bains speaks during a meeting of the special committee on the COVID-19 outbreak, as efforts continue to help slow the spread of the coronavirus disease (COVID-19), in the House of Commons on Parliament Hill in Ottawa, Ontario, Canada May 20, 2020. REUTERS/Blair Gable

A protective face mask with an American flag on it belonging to Ja'Ron Smith, the Deputy Director of the White House Office of American Innovation, sits on the cabinet room table atop papers during a meeting on economic "opportunity zones" with U.S. President Donald Trump during the coronavirus disease (COVID-19) outbreak at the White House in Washington, U.S., May 18, 2020. REUTERS/Leah Millis

Volunteers prepare parts of "Vent-I", an innovation ventilator machine focused on Continuous Positive Airway Pressure (CPAP), commonly used in obstructive sleep apnea treatment, for coronavirus disease (COVID-19) patients, at their workshop in Bandung, West Java province, Indonesia, May 5, 2020. Picture taken May 5, 2020. REUTERS/Willy Kurniawan

Syarif Hidayat, a 57-year-old researcher and lecturer, poses for pictures next to "Vent-I", an innovation ventilator machine focused on Continuous Positive Airway Pressure (CPAP), commonly used in obstructive sleep apnea treatment, for coronavirus disease (COVID-19) patients, at their workshop in Bandung, West Java province, Indonesia, May 5, 2020. Picture taken May 5, 2020. REUTERS/Willy Kurniawan

Syarif Hidayat, a 57-year-old researcher and lecturer, give a brief to volunteers for assembling "Vent-I", an innovation ventilator machine focused on Continuous Positive Airway Pressure (CPAP), commonly used in obstructive sleep apnea treatment, for coronavirus disease (COVID-19) patients, at their workshop in Bandung, West Java province, Indonesia, May 5, 2020. Picture taken May 5, 2020. REUTERS/Willy Kurniawan

Prototype printed-designs of "Vent-I", an innovation ventilator machine focused on Continuous Positive Airway Pressure (CPAP), commonly used in obstructive sleep apnea treatment, for coronavirus disease (COVID-19) patients, are seen at a workshop in Bandung, West Java province, Indonesia, May 5, 2020. Picture taken May 5, 2020. REUTERS/Willy Kurniawan

A volunteer wearing protective mask looks on at a workshop making "Vent-I", an innovation ventilator machine focused on Continuous Positive Airway Pressure (CPAP), commonly used in obstructive sleep apnea treatment, for coronavirus disease (COVID-19) patients, in Bandung, West Java province, Indonesia, May 5, 2020. Picture taken May 5, 2020. REUTERS/Willy Kurniawan

A volunteer prepares covers for "Vent-I", an innovation ventilator machine focused on Continuous Positive Airway Pressure (CPAP), commonly used in obstructive sleep apnea treatment, for coronavirus disease (COVID-19) patients, at their workshop in Bandung, West Java province, Indonesia, May 5, 2020. Picture taken May 5, 2020. REUTERS/Willy Kurniawan

Drinking-tumbler used as part of "Vent-I", an innovation ventilator machine focused on Continuous Positive Airway Pressure (CPAP), commonly used in obstructive sleep apnea treatment, for coronavirus disease (COVID-19) patients, at a workshop in Bandung, West Java province, Indonesia, May 5, 2020. Picture taken May 5, 2020. REUTERS/Willy Kurniawan

A medical specialist holds a testing tube with blood in Hadassah clinic, which offers tests for for antibodies against the coronavirus disease (COVID-19), at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov

A medical specialist wearing protective gear works in Hadassah clinic, which offers tests for antibodies against the coronavirus disease (COVID-19), at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov

A view shows testing tubes in Hadassah clinic, which offers tests for for antibodies against the coronavirus disease (COVID-19), at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov

A medical specialist takes a test for the novel coronavirus (2019-nCoV) in Hadassah clinic at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov

A view shows testing tubes in Hadassah clinic, which offers tests for for antibodies against the coronavirus disease (COVID-19), at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov

A medical specialist takes a test for the novel coronavirus (2019-nCoV) in Hadassah clinic at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov

A medical specialist wearing protective gear works in Hadassah clinic, which offers tests for antibodies against the coronavirus disease (COVID-19), at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov

A medical specialist holds a negative test for the novel coronavirus (2019-nCoV) in Hadassah clinic at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov

A medical specialist takes a test for the novel coronavirus (2019-nCoV) in Hadassah clinic at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov

A medical specialist holds a positive test for the novel coronavirus (2019-nCoV) in Hadassah clinic at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov

A medical specialist wearing protective gear works in Hadassah clinic, which offering tests for antibodies against the coronavirus disease (COVID-19), at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov

A view shows negative tests for the novel coronavirus (2019-nCoV) in Hadassah clinic at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov

Canada's Minister of Innovation, Science and Industry Navdeep Bains speaks in the House of Commons as legislators convene to give the government power to inject billions of dollars in emergency cash to help individuals and businesses through the economic crunch caused by the coronavirus disease (COVID-19) outbreak, on Parliament Hill in Ottawa, Ontario, Canada April 11, 2020. REUTERS/Blair Gable

Ricardo, an industrial designer, holds reusable material to make 3D printer filaments at the Center for Innovation and Advanced Design, during a preventive quarantine after the outbreak of coronavirus disease (COVID-19), in Santiago, Chile, April 1, 2020. REUTERS/Pablo Sanhueza

Detail of a screen showing the time it takes to print the NanoHack mask, at the Center for Innovation and Advanced Design, during a preventive quarantine after the outbreak of coronavirus disease (COVID-19), in Santiago, Chile, April 1, 2020. REUTERS/Pablo Sanhueza

Ricardo, an industrial designer, changes a 3D printer cartridge, at the Center for Innovation and Advanced Design, during a preventive quarantine after the outbreak of coronavirus disease (COVID-19), in Santiago, Chile, on April 1, 2020. REUTERS/Pablo Sanhueza

Detail of a model of the antiviral mask with copper, NanoHack, for 3D printers, in the Center of Innovation and Advanced Design, during a preventive quarantine after the outbreak of the coronavirus disease (COVID-19), in Santiago, Chile, April 1, 2020. REUTERS/Pablo Sanhueza

Daniel Martinez, technical director of Copper3D, poses with the NanoHack mask, for a portrait at the Center for Innovation and Advanced Design, during a preventive quarantine after the outbreak of coronavirus disease (COVID-19), in Santiago, Chile, April 1, 2020. REUTERS/Pablo Sanhueza

Ricardo, an industrial designer, poses with the NanoHack mask, for a portrait at the Center for Innovation and Advanced Design, during a preventive quarantine after the outbreak of coronavirus disease (COVID-19), in Santiago, Chile, April 1, 2020. REUTERS/Pablo Sanhueza

Detail of the antiviral mask with copper, NanoHack, printed in 3D, in the Center of Innovation and Advanced Design, during a preventive quarantine after the outbreak of the coronavirus disease (COVID-19), in Santiago, Chile, April 1, 2020. REUTERS/Pablo Sanhueza

Face shields are displayed at the reception of the Center for Innovation and Advanced Design, during a preventive quarantine after the outbreak of coronavirus disease (COVID-19) in Santiago, Chile, April 1, 2020. REUTERS/Pablo Sanhueza

French Minister of Higher Education, Research and Innovation Frederique Vidal and French Health and Solidarity Minister Olivier Veran speak to the media after the first meeting of French scientists' council Research and Expertise Analysis Committee (CARE), at the Elysee Palace in Paris, France March 24, 2020. Ludovic Marin/Pool via REUTERS

French Minister of Higher Education, Research and Innovation Frederique Vidal and French Health and Solidarity Minister Olivier Veran speak to the media after the first meeting of French scientists' council Research and Expertise Analysis Committee (CARE), at the Elysee Palace in Paris, France March 24, 2020. Ludovic Marin/Pool via REUTERS

French Minister of Higher Education, Research and Innovation Frederique Vidal and French Health and Solidarity Minister Olivier Veran leave after the first meeting of French scientists' council Research and Expertise Analysis Committee (CARE), at the Elysee Palace in Paris, France March 24, 2020. Ludovic Marin/Pool via REUTERS

French Minister of Higher Education, Research and Innovation Frederique Vidal and French Health and Solidarity Minister Olivier Veran speak to the media after the first meeting of French scientists' council Research and Expertise Analysis Committee (CARE), at the Elysee Palace in Paris, France March 24, 2020. Ludovic Marin/Pool via REUTERS

French Minister of Higher Education, Research and Innovation Frederique Vidal and French Health and Solidarity Minister Olivier Veran speak to the media after the first meeting of French scientists' council Research and Expertise Analysis Committee (CARE), at the Elysee Palace in Paris, France March 24, 2020. Ludovic Marin/Pool via REUTERS

Irish Minister for Business, Enterprise and Innovation Heather Humphreys speaks during a news conference on the ongoing situation with the coronavirus disease (COVID-19) at Government Buildings in Dublin, Ireland March 24, 2020. Steve Humphreys/Pool via REUTERS

Irish Minister for Business, Enterprise and Innovation Heather Humphreys speaks during a news conference on the ongoing situation with the coronavirus disease (COVID-19) at Government Buildings in Dublin, Ireland March 24, 2020. Steve Humphreys/Pool via REUTERS

French Presidency chief of staff Alexis Kohler, French Minister of Higher Education, Research and Innovation Frederique Vidal, French President Emmanuel Macron, Prime Minister Edouard Philippe and Health Minister Olivier Veran take part in a conference call to install the CARE committee on the novel coronavirus (COVID-19), at the Elysee Palace in Paris, France March 24, 2020. Ludovic Marin/Pool via REUTERS

French Presidency chief of staff Alexis Kohler, French Minister of Higher Education, Research and Innovation Frederique Vidal, French President Emmanuel Macron, Prime Minister Edouard Philippe and Health Minister Olivier Veran take part in a conference call to install the CARE committee on the novel coronavirus (COVID-19), at the Elysee Palace in Paris, France March 24, 2020. Ludovic Marin/Pool via REUTERS

French Minister of Higher Education, Research and Innovation Frederique Vidal, French President Emmanuel Macron, Prime Minister Edouard Philippe and Health Minister Olivier Veran take part in a conference call to install the CARE committee on the novel coronavirus (COVID-19), at the Elysee Palace in Paris, France March 24, 2020. Ludovic Marin/Pool via REUTERS

Canada's Minister of Agriculture and Agri-Food Marie-Claude Bibeau and Minister of Innovation, Science and Industry Navdeep Bains attend a news conference as efforts continue to help slow the spread of coronavirus disease (COVID-19) in Ottawa, Ontario, Canada March 23, 2020. REUTERS/Blair Gable

Canada's Minister of Innovation, Science and Industry Navdeep Bains attends a news conference as efforts continue to help slow the spread of coronavirus disease (COVID-19) in Ottawa, Ontario, Canada March 23, 2020. REUTERS/Blair Gable

Bruce Greenstein, Executive Vice President and Chief Strategy and Innovation Officer of the LHC Group offers President Donald Trump an elbow bump in place of a handshake for safety as Vice President Mike Pence and Ambassador Debbie Birx, the White House Coronavirus Response Coordinator, look on after the president declared the coronavirus pandemic a national emergency at a news conference in the Rose Garden of the White House in Washington, U.S., March 13, 2020. REUTERS/Jonathan Ernst

Bruce Greenstein, Executive Vice President and Chief Strategy and Innovation Officer of the LHC Group offers President Donald Trump an elbow bump in place of a handshake for safety as Dr Anthony Fauci and Vice President Mike Pence look on after the president declared the coronavirus pandemic a national emergency at a news conference in the Rose Garden of the White House in Washington, U.S., March 13, 2020. REUTERS/Kevin Lamarque

Bruce Greenstein, Executive Vice President and Chief Strategy and Innovation Officer of the LHC Group offers President Donald Trump an elbow bump in place of a handshake for safety as Dr Anthony Fauci and Vice President Mike Pence look on after the president declared the coronavirus pandemic a national emergency at a news conference in the Rose Garden of the White House in Washington, U.S., March 13, 2020. REUTERS/Kevin Lamarque TPX IMAGES OF THE DAY

Greg Niemeyer, a professor of media innovation at University of California, Berkeley, and his colleague, theater and dance professor Lisa Wymore, are seen in his office during an online course they teach together in Berkeley, California, U.S., March 12, 2020. The university has moved most of its courses online in the face of the fast-spreading coronavirus. REUTERS/Nathan Frandino

University of California, Berkeley Professors Lisa Wymore (L) and Greg Niemeyer look at the Zoom screen showing students in their online Collaborative Innovation course in Berkeley, California, U.S., March 12, 2020. REUTERS/Nathan Frandino

Greg Niemeyer, a professor of media innovation at University of California, Berkeley, is seen in his office ahead of an online course in Berkeley, California, U.S., March 12, 2020. The university has moved most of its courses online in the face of the fast-spreading coronavirus. REUTERS/Nathan Frandino

A health worker is seen in a workshop where Mexican engineers develop protective equipments for health care workers treating coronavirus patients at XE Medica, a company which provides medical equipment and services, in Mexico City, Mexico March 10, 2020. Picture taken March 10, 2020. REUTERS/Henry Romero

Health workers pull out a capsule to treat patients infected with coronavirus (Covid19) towards an ambulance outside the XE Medica, a company which provides medical equipment and services, in Mexico City, Mexico March 10, 2020. Picture taken March 10, 2020. REUTERS/Henry Romero

A health worker is seen beside a capsule to treat patients infected with coronavirus (Covid19) outside the XE Medica, a company which provides medical equipment and services, in Mexico City, Mexico March 10, 2020. Picture taken March 10, 2020. REUTERS/Henry Romero

A health worker inspects a capsule to treat patients infected with coronavirus (Covid19) outside the XE Medica, a company which provides medical equipment and services, in Mexico City, Mexico March 10, 2020. Picture taken March 10, 2020. REUTERS/Henry Romero

A health worker pulls out a capsule to treat patients infected with coronavirus (Covid19) towards an ambulance outside the XE Medica, a company which provides medical equipment and services, in Mexico City, Mexico March 10, 2020. Picture taken March 10, 2020. REUTERS/Henry Romero

A Mexican engineer is seen through a plastic capsule to treat patients infected with coronavirus (Covid19) at XE Medica, a company which provides medical equipment and services, in Mexico City, Mexico March 10, 2020. Picture taken March 10, 2020. REUTERS/Henry Romero

A health worker inspects a capsule to treat patients infected with coronavirus (Covid19) at XE Medica, a company which provides medical equipment and services, in Mexico City, Mexico March 10, 2020. Picture taken March 10, 2020. REUTERS/Henry Romero